Related news:Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more
Vaxcyte
Bookmark
ShareVaxcyte is a company. It is located in San Carlos, the United States. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: San Carlos
- state: CA
- country: United States
- sector: Health Care
- industry: Biotechnology
- CEO: Grant E. Pickering M.B.A.
- CEO gender: Male
Classified as: organization
Business
Vaxcyte is one of the companies in the United States, companies in Biotechnology, companies in Health Care and 3,466,499 companies in our database.
- Assets: 324.3M $
- Debt: 22.4M $
- Employees: 89 people
- Free cash flow: -102313000 $
- Market cap: 1.5B $
- Revenues:
Try Pro to see estimates
Stocks from Vaxcyte:
Talking Points:
- Homepage - Vaxcyte
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1
- 2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Learn more about talking points
